News | Proton Therapy | August 10, 2016

New center, which will include a dedicated research bay, expected to treat first patients in September

Cincinnati Children's, UC Health, new Proton Therapy Center

August 10, 2016 — Cincinnati Children's Hospital Medical Center and UC Health are celebrating the grand opening of the new Proton Therapy Center. Located at Cincinnati Children's Liberty Campus, the $120 million facility is one of the most advanced proton research and cancer treatment centers in the world. The first patients are expected to be treated in September.

"This important investment will transform cancer care for children and adults and generate a new wave of discovery," said Michael Fisher, president and CEO at Cincinnati Children's. "Proton is advanced cancer therapy. I am pleased it is now available to our pediatric patients with the most challenging types of cancer, underscoring our deep commitment to always provide the safest and most effective treatment options."

Proton therapy is a form of radiation treatment used for certain types of cancers. The medical procedure involves a type of particle therapy utilizing a beam of protons to blast diseased tissue with remarkable precision. It works by extracting positively charged protons from hydrogen gas and accelerating them through a cyclotron (a particle accelerator) up to nearly 2/3 the speed of light. The protons are guided to the tumor site by powerful magnetic and electrical fields. They carry just enough charge to reach a precise point in the tumor.

Traditional radiation treatment kills targeted cancer cells but can also damage surrounding healthy tissue. It's estimated as much as one-third of the radiation dose a patient receives can wind up deposited away from the targeted tumor. Proton therapy is expected to significantly reduce the risks because of its precision, allowing cancer survivors to have far fewer long-term consequences.

The types of cancer best treated by proton therapy include Hodgkin lymphoma, pediatric brain tumors, neuroblastoma and soft tissue sarcomas. In the adult population, the targeted treatment is specifically helpful in cancers of the brain, eyes, head, neck, lungs, prostate and spinal cord.

The center will have the world's only proton treatment gantry fully dedicated to research along several tracks including: basic biological research to better understand exactly how protons kill cancer cells; applied research and development for evaluating imaging methods, computer-targeting technologies and patient positioning techniques; and translational research to develop and refine other treatments that can augment proton therapy.

The research will be done in cooperation among Cincinnati Children's, UC Medical Center, the University of Cincinnati Physicians, the UC College of Medicine and Varian, the proton equipment manufacturer. Some collaborations will also involve research centers in Germany and Israel. More multi-institutional partnerships are likely.

The Proton Therapy Center features two treatment gantries, one research gantry and a shelled treatment bay for future expansion. One treatment gantry is devoted to pediatric patients and one to adult patients.  The Center, located at Cincinnati Children's Liberty campus, will have separate and clearly-marked entrances for children and adults.

For more information: www.cincinnatichildrens.org


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now